Institutional investors purchased a net $541.6 thousand shares of IPXL during the quarter ended September 2013 and now own 81.86% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Pharmaceuticals: Generic industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BLACKROCK FUND ADVISORS Bought 843.1 Thousand shares of Impax Laboratories Inc
TRADEWINDS GLOBAL INVESTORS LLC Bought 674.3 Thousand shares of Impax Laboratories Inc